Cellectis (CLLS) Other Non-Current Liabilities (2014 - 2026)

Cellectis' (CLLS) quarterly Other Non-Current Liabilities came in at $1.3 million in Q1 2026, up 16.24% year-on-year from $1.1 million in Q1 2025, and little changed quarter-over-quarter from $1.3 million in Q4 2025.

Cellectis (CLLS) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends

Cellectis' Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $1.3 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 16.24% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 16.24% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 19.19% from the prior year.
  • Other Non-Current Liabilities held at $1.3 million in Q1 2026 per CLLS's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.7 million in Q1 2022 and bottomed at $1.1 million in Q4 2024.
  • The 5-year median for Other Non-Current Liabilities is $2.2 million (2024), against an average of $2.1 million.
  • Across the five-year window, Other Non-Current Liabilities plunged 49.32% in 2024 and increased 19.19% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $2.4 million in 2022, then dropped by 7.95% to $2.2 million in 2023, then plunged by 49.32% to $1.1 million in 2024, then rose by 19.19% to $1.3 million in 2025, then retreated by 0.38% to $1.3 million in 2026.
  • Per Business Quant, the three latest CLLS Other Non-Current Liabilities figures stand at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Cellectis 281.48 Mn 95.81 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.32 Mn
Dec 31, 2025 1.33 Mn
Sep 30, 2025 1.34 Mn
Jun 30, 2025 1.30 Mn
Mar 31, 2025 1.14 Mn
Dec 31, 2024 1.12 Mn
Sep 30, 2024 2.43 Mn
Jun 30, 2024 2.19 Mn
Mar 31, 2024 2.24 Mn
Dec 31, 2023 2.20 Mn
Sep 30, 2023 2.56 Mn
Jun 30, 2023 2.64 Mn
Mar 31, 2023 2.54 Mn
Dec 31, 2022 2.39 Mn
Sep 30, 2022 2.65 Mn
Jun 30, 2022 2.85 Mn
Mar 31, 2022 3.72 Mn
Dec 31, 2021 4.07 Mn
Sep 30, 2021 3.85 Mn
Jun 30, 2021 3.61 Mn